Clinical trials
Infarction clinical trials
Below are recruiting infarction clinical trials, each written for real people, not researchers. We’re tracking 393 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07521930Recruiting
Brain implant to restore communication and movement control
This trial tests a surgically implanted brain device designed to help people with severe paralysis or movement disorders regain the ability to communicate and control their limbs. The device reads signals from your brain and translates them into commands that could help you interact with computers or assistive technology.
Baltimore, MarylandAges 18–80 - NCT06633809Recruiting
Treating minor stroke with large artery blockage
This study tests whether a specific treatment (likely endovascular therapy) helps people who have a minor stroke caused by a blockage in a large brain artery. If you are eligible, you may receive this treatment within 24 hours of your stroke to try to improve your recovery.
Hangzhou, ZhejiangAges 18 years+ - NCT06654453Recruiting
Clot removal during heart catheterization after clot-busting medicine
This study tests whether removing a clot with a special suction device during a heart catheterization helps people who already received a clot-busting medicine for a severe heart attack. It may improve blood flow and reduce damage to the heart muscle.
Changsha, HunanAges 18 years+ - NCT06662890Recruiting
Heart attack blood oxygen therapy trial
This trial tests if giving extra oxygen to the blood during a heart attack can help heart muscle recover. It is for people having a specific type of heart attack and balloon treatment.
Clydebank, DunbartonshireAges 18 years+ - NCT06676345Recruiting
Heart Attack Complications Study
This study looks at people who have had a heart attack and developed a related structural problem in the heart (like a tear or valve issue). It aims to learn more about these complications to improve future care.
VareseAges 18 years+ - NCT06699056Recruiting
AI heart monitor study for ejection fraction
This study uses an AI-powered wearable monitor to check how well your heart pumps blood (ejection fraction) from a simple EKG recording. It may help doctors quickly assess heart function without extra tests.
Orange, CaliforniaAges 18 years+ - NCT06701968Recruiting
Healthy Nordic diet for heart artery health after heart attack
This study tests whether a healthy Nordic diet (like whole grains, berries, fish, and vegetables) can slow down hardening of the arteries in people who have had a heart attack or have stable chest pain. It lasts 18 months and aims to improve heart health.
UppsalaAges 50–80 - NCT06712004RecruitingPhase 2
Testing a new stroke drug: different doses for people who cannot get standard care
This trial tests a new medication (bevifibatide) to see which dose works best for people having an ischemic stroke who cannot get standard treatments like clot-busting drugs or a procedure to remove the clot. It aims to improve recovery by stopping clots from getting worse.
Guangzhou, GuangdongAges 18–80 - NCT06731673Recruiting
HSP47 protein study in blood clots
This study looks at a protein called HSP47 in people with blood clots, heart attacks, or strokes caused by atrial fibrillation, compared to healthy volunteers. It aims to learn more about how blood clots form and may lead to better treatments.
Aarhus, Central RegionAges 18 years+ - NCT06753591Recruiting
Premature heart attack registry in Serbia
This trial is creating a registry of young adults (45 and under) who have had a heart attack. It will collect information to help doctors better understand and treat early heart attacks.
BelgradeAges 18–45 - NCT06757764RecruitingPhase 4
Stroke from artery narrowing: testing combination of anti-platelet drugs
This trial tests whether a combination of two or three anti-platelet medicines (like aspirin, clopidogrel, or cilostazol) is safe and works better than one alone for people who had a stroke from a narrowed artery. The goal is to prevent another stroke.
Seoul, Songpa-guAges 20 years+ - NCT06769256RecruitingPhase 4
TNK vs tirofiban for heart attack with large clot
This trial tests a clot-busting drug (TNK) versus a blood thinner (tirofiban) in people having a major heart attack with a large clot. If you qualify, you would get the medicine directly into your heart artery through a thin tube to see which works better.
Zhengzhou, HenanAges 18–75 - NCT06788275Recruiting
Can exercise improve blood vessel health after a heart attack?
This study looks at whether aerobic exercise can improve blood vessel health in people who have had a heart attack or chest pain (angina). If you qualify, you'll join a monitored exercise program.
Alicante, AlicanteAges 45–75 - NCT06792643RecruitingPhase 2
Cangrelor for heart attack patients on heart-lung support
This trial tests whether adding a fast-acting anti-clotting drug (cangrelor) helps people having a massive heart attack who need a heart-lung machine (VA-ECMO). The goal is to see if it reduces clotting risks without causing dangerous bleeding.
Milan, ItalyAges 18 years+ - NCT06795035Recruiting
Coronary microvascular testing after heart attack
This study tests a way to measure tiny blood vessels in the heart after a major heart attack (STEMI) using a special catheter with salt water. The goal is to see if this test helps doctors understand how well your heart is healing.
Cleveland, OhioAges 18 years+ - NCT06842745RecruitingPhase 2
Brain stimulation plus language therapy for mild aphasia
This study tests whether combining brain stimulation (TMS) with language therapy can help people with mild aphasia after a stroke. It aims to improve speaking and understanding.
Philadelphia, PennsylvaniaAges 40–85 - NCT06847568RecruitingPhase 3
Adrenaline during heart artery procedure to prevent poor blood flow
This study tests whether giving adrenaline (a medicine that helps blood vessels relax) directly into the heart artery during a procedure to open a blocked artery can prevent a complication called 'no reflow' (where blood still doesn't flow well after the blockage is cleared). It is for people having a specific type of heart attack (STEMI) and being treated within 12 hours.
CairoAges 18 years+ - NCT06857838Recruiting
Bypass surgery for symptomatic myocardial bridge
This trial tests whether bypass surgery is effective for people with a myocardial bridge (a heart muscle that arches over an artery) that still causes symptoms despite medication. It aims to see if surgery can improve symptoms and outcomes.
Xi'an, ShaanxiAges 18–80 - NCT06880978Recruiting
Comparing two stent methods for Y-shaped heart blockages
This study compares two stent-placing techniques for people with a specific type of complex heart blockage at a branch point. It aims to see which method is safer and more effective for opening up the artery.
IstanbulAges 18 years+ - NCT06885619Recruiting
Predicting heart outcomes after a first heart attack with blood tests
This study looks at blood tests and heart function after a first heart attack (STEMI) treated with emergency stenting. Researchers want to see if certain molecules in the blood can predict future heart problems.
Beijing, Beijing MunicipalityAges 18–80 - NCT06891456Recruiting
Pulsed field ablation for ventricular tachycardia after heart attack
This trial tests a new type of energy (pulsed field ablation) to treat a fast heart rhythm called ventricular tachycardia that happens after a heart attack. The goal is to stop the dangerous rhythm without damaging nearby healthy tissue.
Cleveland, OhioAges 18 years+ - NCT06906432Recruiting
Brain-Heart Injury After Brain Bleed Study
This study looks at how a brain bleed can affect the heart. Researchers hope to understand the link between brain and heart injury to help improve care for people who have had a brain bleed.
Beijing, Beijing MunicipalityAges 18–80 - NCT06927739RecruitingPhase 2
Orticumab for heart artery inflammation after a heart attack
This trial tests a drug called orticumab to see if it can reduce inflammation in the arteries of the heart after a heart attack. It may help prevent future heart problems.
Los Angeles, CaliforniaAges 18 years+ - NCT06927791Recruiting
Using AI to spot heart problems earlier
This trial uses machine learning (a type of artificial intelligence) to help doctors diagnose acute heart or vessel conditions faster. It may lead to quicker treatment for patients with sudden heart problems.
BaselAges 18 years+
Hear when a new Infarction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for infarction?
- Yes. Clin2 currently lists 393 recruiting infarction studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a infarction trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a infarction trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.